US 12,794,638

Application 17/626,471 · Granted Nov 10, 2026

Signal transmission method, device, communication node, and storage medium

Estimated expiration

October 1, 2041

14y 318d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTCN2020104509: Resource not found (404)
Earliest effective filing
Jul 24, 2020
+ 20 years
Jul 24, 2040
PTA +434d
Oct 1, 2041
No TD
—
Final
Oct 1, 2041

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
January 11, 2022
Earliest effective filing
July 24, 2020
Issue date
November 10, 2026
PTA
+434 days
Base expiry (before PTA)
July 24, 2040

July 24, 2020 + 20 years = July 24, 2040 + 434 PTA days = October 1, 2041

  • National stage entry of application PCTCN2020104509, filed Jul 24, 2020

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/626,471 · US 12,794,638

PatentReply compiles the prosecution history behind US 12,794,638: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12794638

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.